EU Suspends Ulipristal Pending Further Review

Action Prompted By Another Case Of Serious Liver Injury

 
• By Ian Schofield

Gedeon Richter's Esmya should not be prescribed to women while the European Medicines Agency again reviews the risk of serious hepatic injury.

Folders_Risk_Assessment
Ulipristal is being scrutinized over the risk of liver damage • Source: Shutterstock

More from Regulation

More from Policy & Regulation